Status:
COMPLETED
Construction and Use of Lung Tumor Microarray for the Analysis of Gene Expression in Lung Cancer
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Lung Cancer
Eligibility:
All Genders
Brief Summary
The proposed research intends to construct a set of tissue microarrays containing different types of normal and lung cancer tissues for the study of genes associated with lung cancer. Thus far we have...
Detailed Description
The proposed research intends to construct a set of tissue microarrays containing different types of lung cancer tissues for the study of genes associated with lung cancer. In this study, lung tissue ...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA
- The human tissue microarrays will include existing archival tissues of normal lung, non small-cell lung cancer, and combined histological types of lung cancer samples. All tissue samples are already in existence at the Armed Forces Institute of Pathology.
- The primary selection criteria will be the type of cancer, the quality of the tumor block, and the availability of the sample without regard to age, race, ethnic origin, and gender of the patient.
- Only tissue blocks of suitable fixation quality and proper diagnosis will be used to generate the lung tissue microarrays.
Exclusion
Key Trial Info
Start Date :
August 9 2001
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 19 2010
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00340847
Start Date
August 9 2001
End Date
May 19 2010
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute (NCI), 9000 Rockville Pike
Bethesda, Maryland, United States, 20892